TBPMF News and Press, Tetra Bio-Pharma Inc From 02/13/20

Tetra Bio-Pharma Announces Closing of Bought Deal Financing Canada NewsWire OTTAWA, Feb. 13, 2020 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA , Feb. 13, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc. (" Te...

Image Source: Analytical Cannabis Company Thesis Tetra Bio Pharma ( OTCQB:TBPMF ) is one of the first companies in the marijuana industry to study the potential effects of analgesia with cannabinoids. Currently, TBMPF's leading clinical trials involves CAUMZ and QIXLEEF (9.5% Dry Pellet TH...

Tetra Bio-Pharma (TSXV: TBP ,OTCQB:TBPMF) has stepped closer to receiving fast track designation from the US Food and Drug Administration (FDA) for its drug-device combination, which aims to treat patients with incurable malignant cancer. Monday’s (February 3) announcement follows a...

Tetra Bio-Pharma Receives Favorable Response Following Type B Meeting with USA FDA for CAUMZ™ Canada NewsWire OTTAWA, Jan. 31, 2020 OTTAWA , Jan. 31, 2020 /CNW Telbec/ -  Tetra Bio-Pharma Inc . (" Tetra " or the " Company ") (TSXV: TBP) (OTCQB: TBPMF), a leade...

Tetra’s sterile cannabinoid manufacturing facility fully validated and operational Tetra’s subsidiary, Panag Pharma, ready to initiate the treatment phase of clinical trial of PPP003 for treatment of eye pain OTTAWA, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma I...

Tetra Bio-Pharma Announces Upsizing of Previously Announced Offering Canada NewsWire ORLEANS, ON, Jan. 27, 2020 /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES / ORLEANS, ON , Jan. 27, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc...

During the past trading week (January 20 to 24), a Canadian cannabis producer announced a massive, multi-million dollar influx of cash from a mysterious benefactor. TMX Group (TSX: X ) unveiled a new index that tracks the performance of the biggest cannabis companies on its exchanges, and a ...

After receiving two drug identification numbers from Health Canada last week, Tetra Bio-Pharma (TSXV: TBP ,OTCQB:TBPMF) is now looking to get its products to market within this calendar year. On Monday (January 20), the Canadian maker of cannabinoid-based drugs told investors that, with ...

TETRA BIO-PHARMA - PRESS RELEASE CORRECTION Canada NewsWire OTTAWA, Jan. 22, 2020 /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES / OTTAWA , Jan. 22, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc.(TSXV:TBP) ("Tetra" or "TBP") anno...

Tetra Bio-Pharma ( OTCQB:TBPMF ) inks an agreement with Echelon Wealth Partners for the purchase of ~18.9M units at C$0.53 per unit for a total of C$10M. More news on: Tetra Bio-Pharma Inc., Healthcare stocks news, Read more ...